Search

Your search keyword '"Smith, Porsha"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Smith, Porsha" Remove constraint Author: "Smith, Porsha"
19 results on '"Smith, Porsha"'

Search Results

1. Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation

2. Data from Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

3. Supplementary Materials, Figure Legends, and Tables from Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

4. Supplementary Figures 1 - 7 from Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

5. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

6. Constitutive PRMT5 Expression Drives Spontaneous Lymphoblastic Lymphoma In Vivo

7. Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder.

9. Abstract 4691: Role of select T helper cell subsets in the development of Epstein-Barr virus-driven lymphoproliferative disease

10. PRMT5 Transgenic Mice Develop Aggressive Lymphoblastic Lymphomas

11. Epigenetic modulation of inflammatory T cell responses

12. Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

13. Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing

14. Protein Arginine Methyltransferase 5 (PRMT5) Over-Expression Is Essential for Epstein-Barr Virus-Driven B-Cell Transformation.

15. Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma

16. Protein Arginine Methyltransferase 5 as a Driver of Lymphomagenesis

17. Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation

18. Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing.

19. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

Catalog

Books, media, physical & digital resources